Cargando…

Integrin-Mediated Delivery of Drugs and Nucleic Acids for Anti-Angiogenic Cancer Therapy: Current Landscape and Remaining Challenges

Angiogenesis, sprouting of new blood vessels from pre-existing vasculatures, plays a critical role in regulating tumor growth. Binding interactions between integrin, a heterodimeric transmembrane glycoprotein receptor, and its extracellular matrix (ECM) protein ligands govern the angiogenic potentia...

Descripción completa

Detalles Bibliográficos
Autor principal:	Majumder, Poulami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315429/ https://www.ncbi.nlm.nih.gov/pubmed/30241287 http://dx.doi.org/10.3390/bioengineering5040076

Ejemplares similares

Delivery Systems for In Vivo Use of Nucleic Acid Drugs
por: Resende, R.R, et al.
Publicado: (2007)

The current landscape of nucleic acid tests for filovirus detection
por: Clark, David J., et al.
Publicado: (2018)

Anti-Angiogenic Therapy: Current Challenges and Future Perspectives
por: Lopes-Coelho, Filipa, et al.
Publicado: (2021)

ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery
por: Hueso, Miguel, et al.
Publicado: (2021)

Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
por: Abdalla, Ahmed M.E., et al.
Publicado: (2018)

Eosinophilic Fasciitis: Current and Remaining Challenges
por: Mazilu, Diana, et al.
Publicado: (2023)

Delivery of Nucleic Acids
por: Mastrobattista, Enrico, et al.
Publicado: (2007)

Nucleic Acid Delivery
por: Lu, Zheng-Rong, et al.
Publicado: (2023)

An Overview of the Stability and Delivery Challenges of Commercial Nucleic Acid Therapeutics
por: Ingle, Rahul G., et al.
Publicado: (2023)

HDL as a drug and nucleic acid delivery vehicle
por: Lacko, Andras G., et al.
Publicado: (2015)

Precision spherical nucleic acids for delivery of anticancer drugs
por: Bousmail, Danny, et al.
Publicado: (2017)

Impact of Peptide Sequences on Their Structure and Function: Mimicking of Virus‐Like Nanoparticles for Nucleic Acid Delivery
por: Jana, Poulami, et al.
Publicado: (2022)

Rapid detection methods for foodborne pathogens based on nucleic acid amplification: Recent advances, remaining challenges, and possible opportunities
por: Ndraha, Nodali, et al.
Publicado: (2023)

Sales for anti-angiogenic drugs
por: Ribatti, Domenico
Publicado: (2017)

The Landscape of Nucleic-Acid-Based Aptamers for Treatment of Hematologic Malignancies: Challenges and Future Directions
por: Wang, Si Chun, et al.
Publicado: (2022)

Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications
por: Shtykalova, Sofia, et al.
Publicado: (2023)

Delivery of Nucleic Acids and Nanomaterials by Cell-Penetrating Peptides: Opportunities and Challenges
por: Huang, Yue-Wern, et al.
Publicado: (2015)

The Multifaceted Histidine-Based Carriers for Nucleic Acid Delivery: Advances and Challenges
por: He, Jiaxi, et al.
Publicado: (2020)

Extracellular Vesicles for Therapeutic Nucleic Acid Delivery: Loading Strategies and Challenges
por: Oshchepkova, Anastasiya, et al.
Publicado: (2023)

Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
por: Palmerston Mendes, Livia, et al.
Publicado: (2017)

Framework nucleic acids as programmable carrier for transdermal drug delivery
por: Wiraja, Christian, et al.
Publicado: (2019)

Chitosans for delivery of nucleic acids()
por: Buschmann, Michael D., et al.
Publicado: (2013)

Unravelling the genomic landscape of leukemia using NGS techniques: the challenge remains
por: Kim, Jieun
Publicado: (2017)

Imaging of Hepatitis B Virus Nucleic Acids: Current Advances and Challenges
por: Bustamante-Jaramillo, Luisa F., et al.
Publicado: (2022)

Nucleic Acid Drugs—Current Status, Issues, and Expectations for Exosomes
por: Yamada, Yoji
Publicado: (2021)

Advances and Challenges of Stimuli-Responsive Nucleic Acids Delivery System in Gene Therapy
por: Lin, Meng, et al.
Publicado: (2023)

Trends and Challenges in Tumor Anti-Angiogenic Therapies
por: Jászai, József, et al.
Publicado: (2019)

Current successes and remaining challenges in protein function prediction
por: Jeffery, Constance J.
Publicado: (2023)

Improving Drug Discovery by Nucleic Acid Delivery in Engineered Human Microlivers
por: Mancio-Silva, Liliana, et al.
Publicado: (2019)

DNA Functional Nanomaterials for Controlled Delivery of Nucleic Acid-Based Drugs
por: Lv, Zhaoyue, et al.
Publicado: (2021)

Reactive resistance to anti-angiogenic drugs
por: Bousquet, Guilhem, et al.
Publicado: (2015)

Optimal control methods for drug delivery in cancerous tumour by anti‐angiogenic therapy and chemotherapy
por: Khalili, Pariya, et al.
Publicado: (2021)

Computational Multi-Scale Modeling of Drug Delivery into an Anti-Angiogenic Therapy-Treated Tumor
por: Mohammadi, Mahya, et al.
Publicado: (2023)

Energy Landscapes of Deoxyxylo- and Xylo-Nucleic Acid Octamers
por: Sharpe, Daniel J., et al.
Publicado: (2020)

Nucleic acid liquid biopsies in Alzheimer's disease: current state, challenges, and opportunities
por: Soelter, Tabea M., et al.
Publicado: (2022)

Vicrostatin – An Anti-Invasive Multi-Integrin Targeting Chimeric Disintegrin with Tumor Anti-Angiogenic and Pro-Apoptotic Activities
por: Minea, Radu O., et al.
Publicado: (2010)

Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma
por: Guarnaccia, Laura, et al.
Publicado: (2021)

Current trends in delivery of non-viral nucleic acid-based therapeutics for improved efficacy
por: Avci-Adali, Meltem, et al.
Publicado: (2022)

Cationic Niosomes as Non-Viral Vehicles for Nucleic Acids: Challenges and Opportunities in Gene Delivery
por: Grijalvo, Santiago, et al.
Publicado: (2019)

The functions and applications of A7R in anti-angiogenic therapy, imaging and drug delivery systems
por: Lu, Lu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tr1pv83djq6ard3dd6knvcvm45